Sanofi: Sleep Initiation and Maintenance Disorders trials
The registry lists 18 Sleep Initiation and Maintenance Disorders studies with Sanofi as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 1Phase 3 12Phase 4 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaCompletedNCT00913614Phase 1
- Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesCompletedNCT00805350Phase 3
- Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesTerminatedNCT00788515Phase 3
- Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesCompletedNCT00679900Phase 3
- Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaCompletedNCT00630175Phase 3
- Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes MellitusCompletedNCT00495885Phase 3
- Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic StudyCompletedNCT00464243Phase 3
- Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes MellitusTerminatedNCT00464061Phase 3
- Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)CompletedNCT00425243Phase 3
- Stilnox Treatment in Elderly Patients With InsomniaCompletedNCT00359229Phase 4
- Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated InsomniaCompletedNCT00318448Phase 3
- Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaCompletedNCT00308503Phase 3
- Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)CompletedNCT00296790Phase 4
- Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With LexaproCompletedNCT00296179Phase 4
- STILDEP: Zolpidem in Depressive and Dysthimic PatientsCompletedNCT00292734Phase 4
- Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs PlaceboCompletedNCT00283790Phase 4
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance InsomniaCompletedNCT00253968Phase 3
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 YearCompletedNCT00253903Phase 3